TD Cowen Initiates Coverage on Option Care Health (NASDAQ:OPCH)

TD Cowen initiated coverage on shares of Option Care Health (NASDAQ:OPCH) in a research report released on Thursday morning, MarketBeat reports. The brokerage issued a hold rating and a $30.00 price target on the stock.

Other equities research analysts also recently issued reports about the company. Citigroup reiterated an “outperform” rating on shares of Option Care Health in a report on Thursday, July 31st. Cowen assumed coverage on shares of Option Care Health in a research note on Thursday. They set a “hold” rating on the stock. JMP Securities upped their target price on shares of Option Care Health from $36.00 to $38.00 and gave the company a “market outperform” rating in a research note on Thursday, July 31st. Finally, Barrington Research reaffirmed an “outperform” rating and set a $38.00 price target on shares of Option Care Health in a report on Tuesday, September 23rd. Eight investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, Option Care Health currently has an average rating of “Moderate Buy” and an average target price of $35.11.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $27.50 on Thursday. The firm’s fifty day simple moving average is $28.36 and its 200 day simple moving average is $30.81. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. Option Care Health has a twelve month low of $21.39 and a twelve month high of $35.53. The firm has a market capitalization of $4.46 billion, a price-to-earnings ratio of 22.00, a PEG ratio of 1.67 and a beta of 0.88.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.01. The firm had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The firm’s quarterly revenue was up 15.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.30 EPS. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, equities research analysts expect that Option Care Health will post 1.22 earnings per share for the current fiscal year.

Insider Buying and Selling at Option Care Health

In related news, Director Timothy P. Sullivan bought 20,000 shares of the stock in a transaction dated Thursday, August 21st. The stock was bought at an average cost of $27.51 per share, with a total value of $550,200.00. Following the completion of the acquisition, the director owned 49,229 shares of the company’s stock, valued at $1,354,289.79. This trade represents a 68.43% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Norman L. Wright purchased 3,411 shares of the business’s stock in a transaction that occurred on Tuesday, September 9th. The stock was bought at an average cost of $29.31 per share, for a total transaction of $99,976.41. Following the acquisition, the director owned 15,501 shares in the company, valued at approximately $454,334.31. The trade was a 28.21% increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 59,411 shares of company stock worth $1,627,576 over the last ninety days. Company insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

Hedge funds and other institutional investors have recently modified their holdings of the company. Durable Capital Partners LP increased its holdings in shares of Option Care Health by 134.2% in the 2nd quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after acquiring an additional 4,720,988 shares during the period. Fuller & Thaler Asset Management Inc. grew its position in Option Care Health by 30.8% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 4,204,481 shares of the company’s stock worth $146,947,000 after purchasing an additional 989,048 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its stake in shares of Option Care Health by 109.0% in the second quarter. Arrowstreet Capital Limited Partnership now owns 3,410,394 shares of the company’s stock valued at $110,770,000 after purchasing an additional 1,778,279 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in shares of Option Care Health by 4.0% during the first quarter. Charles Schwab Investment Management Inc. now owns 2,609,705 shares of the company’s stock valued at $91,209,000 after buying an additional 99,574 shares during the last quarter. Finally, Norges Bank acquired a new position in shares of Option Care Health during the second quarter worth approximately $69,932,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.